03 Profile
Vital Signsby Bridgehead
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Cosmetic procedures & aesthetics
Roopal Thakkar, M.D.: no photograph is held, so the academic plate is shown instead.
Academic
Roopal Thakkar, M.D.
Chief Scientific Officer and EVP of R&D at AbbVie
Apr 2026MayJuneJulyAugSeptOctNovto date
2
Quoted in the press, across 2 topics since 24 Apr 2026
02 Quoted on · 1 of 29 topics
Roopal Thakkar, M.D.: key facts
- Kind of voice
- Academic
- Role
- Chief Scientific Officer and EVP of R&D at AbbVie
- Quoted on
- Cosmetic procedures & aesthetics
- Press coverage
- Quoted in the press
- Most recently quoted
- 22 May 2026
- First quoted
- 24 Apr 2026
04 The signal · where Roopal Thakkar, M.D. sits on cosmetic procedures & aesthetics
Quoted
Quoted in the press on cosmetic procedures & aesthetics.
Placed by press coverage on this topic only, not across all topics.
Ashton CollinsSector leaderDirector, Save FaceLeading
Nora NugentClinicianConsultant Plastic Surgeon and co-owner/Director; Immediate Past President of BAAPS (President 2024–2026), Purity BridgeLeading- Dr Ahmed El MuntasarClinicianFounder and Medical Director; NHS GP, The Aesthetics Doctor (Dr Ahmed Clinics Ltd)Leading
- Andrew RankinSector leadertrustee of the Joint Council of Cosmetic Practitioners
- Dr Barbara KubickaSector leaderfounder of ClinicBe
- Roopal Thakkar, M.D.AcademicChief Scientific Officer and EVP of R&D at AbbVie
- Dr. Charles RunelsClinicianCosmetic procedures expert
- Morgan RabachAcademicboard-certified dermatologist and co-founder of Rabach Aesthetics, a dermatology and facial plastic surgery clinic
Showing the leading voices and those placed around Roopal Thakkar, M.D. · See every voice on the topic →
05 On the record · press
What Roopal Thakkar, M.D. has said
By outlet · bar length shows relative volume
- fiercepharma.com
Where Roopal Thakkar, M.D. has been quoted
- AbbVie plots 85 summer layoffs tied to Allergan aesthetics unit in Californiafiercepharma.com · 22 May 2026
- FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLsfiercepharma.com · 24 Apr 2026
- AbbVie, Grace Therapeutics receive manufacturing-related CRLsfiercepharma.com · 24 Apr 2026
How we found the articles that name Roopal Thakkar, M.D.: we searched news for these terms.
- cosmetic procedures
- non-surgical cosmetic procedures
- Botox
- botulinum toxin
- dermal fillers
- cosmetic fillers
- lip fillers
- aesthetic medicine
Also searched with “cosmetic procedures” in each of 8 national papers, and in the Guardian by editor tag. Every term for Cosmetic procedures & aesthetics
Verbatim
“well-positioned to respond to the agency's feedback promptly to support completion of the review”
“We strongly believe trenibotulinumtoxinE is an important innovation in botulinum toxin science, with the potential to expand options for patients interested in facial aesthetics. Though disappointed, we remain confident in the strength and integrity of our application, and we are well-positioned to respond to the agency's feedback promptly to support completion of the review.”
“We strongly believe trenibotulinumtoxinE is an important innovation in botulinum toxin science, with the potential to expand options for patients interested in facial aesthetics.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.